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Identity 
Hugo: HIC1 
Other names: ZBTB29 
Location: 17p13.3. 
Local order: Close to the D17S5/D17S30/YNZ22 
micro satellite marker which is a highly polymorphic 
variable number of tandem repeats (VNTR) marker. 
Aberrant hypermethylation in tumours of a cluster of 
methylation-sensitive NotI restriction sites surrounding 
this marker allowed the positional cloning of HIC1 in 
1995. 
Telomere, OVCA1/DPH2L1, OVCA2, HIC1, 
KIAA0732, ....Centromere. 
Note: OVCA1/DPH2L1 and OVCA2 are two tumour 
suppressor genes deleted in ovarian cancers. 
DNA/RNA 
Description 
The HIC1 gene extends approximately 15 Kbp and 
consists of four exons. The first three exons 1a, 1b and 
1c are alternative. Note that exon 1a is included in exon 
1c. The major transcripts are derived from alternative 
promoters associated with exon 1a and 1b. Exon 1c is 
conserved in rodent genomes (rat and mice) but 
transcripts containing it are very minor. 
The fourth exon, exon 2, contains the coding region 
and the 3' untranslated region. 
An in-frame upstream ATG initiation codon is also 
found in exon 1b. This upstream reading frame is 
conserved in mice. 
Transcription 
3.0 Kb mRNA. 
Pseudogene 
No known pseudogene. 
 
Protein 
Description 
714 amino acids; around 80kDa; Transcription factor 
belonging to the BTB/POZ and Krüppel C2H2 zinc 
fingers family. There is no experimental evidence for 
the existence of a protein initiated by the upstream 
ATG (e.g. through the use of antipeptide specific 
antibodies). 
Expression 
Based on Northern Blots and RT-PCR experiments, 
HIC1 is widely expressed in various normal tissues. 
Localisation 
Nucleus. Localized on nuclear dots upon 
overexpression by transient transfection assays in COS-
7 or HEK293 cells.  
In human primary fibroblats (WI38), the endogenous 
HIC1 proteins are localized in discrete nuclear 
structures called 'HIC1 bodies'. 
Function 
HIC1 is a transcriptional repressor belonging to the
BTB/POZ and Krüppel C2H2 family (44 proteins in the 
human genome). HIC1 interacts with the corepressor 
CtBP through a conserved GLDLSKK motif in the 
central region. This central region also contains a 
SUMOylation site MK314HEP which is important for 
the transcriptional repression potential of HIC1. This 
K314 is also subject to a reversible 
acetylation/deacetylation implicating CBP/P300 and 
the NAD+ dependent class III deacetylase SIRT1. 
Homology 
HIC1 shares distant homology through the conserved 
BTB/POZ domain and C2H2 zinc fingers domain with 
several BTB/POZ transcriptional repressors. 
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Mutations 
Germinal 
No germinal coding sequence mutations have been 
described for HIC1. 
Somatic 
No somatic coding sequence mutations have been 
described for HIC1 with one exception. During the 
screening of a panel of 68 medulloblastomas using 
SSCP analyses, a 12-bp deletion in the second exon of 
HIC1 has been identified. This results in a deletion of 4 
glycine residues in a stretch of 8 located just after the 
BTB/POZ domain. The other regions of the protein 
specially the downstream central region and the zinc 
fingers domain are not affected by this deletion. 
Epigenetics 
There are a number of reports highlighting differences 
in promoter methylation status in primary human 
tumours (breast, ovaries, prostate, ...) compared to 
matched normal tissues, hence the name of the gene.
Implicated in 
Medulloblastomas, breast tumours, 
ovary tumours, prostate tumours 
Note: (see above). 
Breakpoints 
Note: No breakpoint in HIC1 identified so far. 
To be noted 
Note: A paralog called HIC2, HRG22 or KIAA1020 is 
found on human chromosome 22. It is located in 
22q11.2 in a region subject to translocations (BCRL-2 
for Breakpoint Cluster Region-Like 2). But so far, there 
is no experimental evidence for a translocation 
implicating HRG22 or for its aberrant 
hypermethylation in tumours. 
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